SCHEMBL7250343

SCHEMBL7250343

COc1cc(C(O)c2cccc(C)c2)c(Oc2c(Br)cc(CC(=O)O)cc2Br)cc1NC(=O)c1cccc(C)c1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.57
KMT2A Q03164 6/20 0.44
MEN1 O00255 5/20 0.44
ALDH1A1 P00352 4/20 0.44
LMNA P02545 3/20 0.44
KDM4E B2RXH2 1/20 0.43
GAA P10253 1/20 0.43
FFAR1 O14842 1/20 0.43
TP53 P04637 1/20 0.43
GLA P06280 1/20 0.43
MAPT P10636 3/20 0.40
MAPK1 P28482 1/20 0.39
AHR P35869 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
OPRM1 P35372 1/20 0.38
OPRD1 P41143 1/20 0.38
THRA P10827 1/20 0.38
THRB P10828 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7250975 0.92 NR3C1 (0.54) NR3C1KMT2AMEN1ALDH1A1GAA
SCHEMBL7250938 0.86 NR3C1 (0.57) NR3C1THRATHRB
SCHEMBL7249537 0.84 NR3C1 (0.70) NR3C1THRATHRB
SCHEMBL7587266 0.82 NR3C1 (0.55) NR3C1THRATHRB
SCHEMBL7553498 0.81 NR3C1 (0.52) NR3C1THRATHRB
SCHEMBL7255589 0.79 NR3C1 (0.57) NR3C1THRATHRB
SCHEMBL7252317 0.78 NR3C1 (0.51) NR3C1THRATHRB
SCHEMBL7257439 0.78 NR3C1 (0.73) NR3C1KMT2AMEN1ALDH1A1LMNA
SCHEMBL7250267 0.77 NR3C1 (0.61) NR3C1THRATHRB
SCHEMBL7256747 0.77 NR3C1 (0.62) NR3C1KMT2AMEN1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030166725-A1 Compounds active at the glucocorticoid receptor KARO BIO AB (SE) 2003-09-04 US claimed
EP-1265839-A1 COMPOUNDS ACTIVE AT THE GLUCOCORTICOID RECEPTOR KARO BIO AB (SE) 2002-12-18 EP claimed
WO-2001047859-A1 COMPOUNDS ACTIVE AT THE GLUCOCORTICOID RECEPTOR KARO BIO AB (SE) 2001-07-05 WO claimed
US-20030166725-A1 Compounds active at the glucocorticoid receptor KARO BIO AB (SE) 2003-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030166725-A1 Compounds active at the glucocorticoid receptor NR3C1, NR3C2, GPR119 NR3C1 1/4885KMT2A 3982/4885MEN1 2906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.